6 Questions About Afatinib on Anti-Caners(NSCLC)

Page 1

www.aasraw.com

6 Questions About Afatinib on Anti-Caners(NSCLC)

6 QuestionsAboutAfatinib onAnti-Caners(NSCLC)............................................................................... 1 What Is Afatinib?............................................................................................................................2 When We Need Afatinib? ............................................................................................................. 2 How Does Afatinib Work?..............................................................................................................2 Was Afatinib Approved by FDA? Sure............................................................................................3 What Risk/Side effects Does Afatinib Bring? .................................................................................. 4 What Other ResearchsAbout Afatinib?.......................................................................................... 5 ❶ Afatinib (BIBW 2992) development in non-small-cell lung cancer........................................ 5 ❷ Afatinib in locally advanced and metastatic chordoma........................................................ 6 Reference............................................................................................................................. 6

1

AASraw Biochemical Technology Co.,Ltd aas14@aasraw.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.